Medical Device Network on MSN12d
Cardiac Dimensions snags $53m for mitral valve deviceCardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...
The chordae tendineae (CT), often referred to as the “heart strings,” are thin, tendinous structures that connect the heart ...
Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the successful completion of a Series C funding round worth $22 million. The ...
Growing investments in healthcare infrastructure and advancements in medical research facilities are driving the expansion of ...
Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.
Rising prevalence of cardiovascular diseases and rapid advancements in minimally invasive procedures are fueling the growth ...
Healthcare Asia Magazine on MSN16d
What factors drive the cardiac valve repair devices market in MEA?Mitral valve annuloplasty devices are expected to see the highest growth in the region. Increased investments in healthcare infrastructure, advancements in medical research, and a growing elderly ...
Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and ...
Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s mitral valve repair device. The round was led by investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback